Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a …

JS Smolen, P Nash, P Durez, S Hall, E Ilivanova… - The Lancet, 2013 - thelancet.com
Background Clinical remission and low disease activity are essential treatment targets in
patients with rheumatoid arthritis. Although moderately active rheumatoid arthritis is …

Female patients with ankylosing spondylitis: analysis of the impact of gender across treatment studies

IE van der Horst-Bruinsma, DJ Zack… - Annals of the …, 2013 - ard.bmj.com
Objectives To examine the impact (if any) of gender on the clinical, functional and patient-
reported outcomes of treatment using data pooled from four controlled clinical trials …

How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?

R Fleischmann, D van der Heijde, AS Koenig… - Annals of the …, 2015 - ard.bmj.com
Objectives Disease Activity Score in 28 joints calculated with C-reactive protein (DAS28-
CRP) is used instead of erythrocyte sedimentation rate (DAS28-ESR) to assess rheumatoid …

DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeable

RM Fleischmann, D van der Heijde, PV Gardiner… - RMD open, 2017 - rmdopen.bmj.com
Background In most patients with rheumatoid arthritis (RA), Disease Activity Score 28-joint
count C reactive protein (DAS28-CRP) is lower than DAS28 erythrocyte sedimentation rate …

[HTML][HTML] MRI evidence of structural changes in the sacroiliac joints of patients with non-radiographic axial spondyloarthritis even in the absence of MRI inflammation

WP Maksymowych, S Wichuk, M Dougados… - Arthritis research & …, 2017 - Springer
Background Studies have shown that structural lesions may be present in patients with non-
radiographic axial spondyloarthritis (nr-axSpA). However, the relevance of structural lesions …

[HTML][HTML] Discordance between patient and physician assessments of global disease activity in rheumatoid arthritis and association with work productivity

JS Smolen, V Strand, AS Koenig, A Szumski… - Arthritis Research & …, 2016 - Springer
Background Discordance between patient and physician ratings of rheumatoid arthritis (RA)
severity occurs in clinical practice and correlates with pain scores and measurements of joint …

Resilience as a predictor of treatment response in patients with posttraumatic stress disorder treated with venlafaxine extended release or placebo

J Davidson, DJ Stein, BO Rothbaum… - Journal of …, 2012 - journals.sagepub.com
This post-hoc analysis evaluated resilience as a predictor of treatment response in patients
with posttraumatic stress disorder (PTSD). Data were pooled from two randomized, double …

Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non …

WP Maksymowych, S Wichuk, M Dougados… - Annals of the …, 2018 - ard.bmj.com
Objective To evaluate the impact on structural lesions observed on MRI in the sacroiliac
joints (SIJ) at 12 weeks in patients with non-radiographic axial spondyloarthritis (nr-axSpA) …

Evaluation of the change in structural radiographic sacroiliac joint damage after 2 years of etanercept therapy (EMBARK trial) in comparison to a contemporary control …

M Dougados, WP Maksymowych… - Annals of the …, 2018 - ard.bmj.com
Objective To compare 2 years of radiographic sacroiliac joint (SIJ) changes in patients with
recent onset axial spondyloarthritis (axSpA) receiving etanercept in a clinical trial (EMBARK) …

Predictors of clinical remission under anti-tumor necrosis factor treatment in patients with ankylosing spondylitis: pooled analysis from large randomized clinical trials

X Baraliakos, AS Koenig, H Jones, A Szumski… - The Journal of …, 2015 - jrheum.org
Objective. Investigate the role and relation of disease duration of different factors for
achieving clinical remission with anti-tumor necrosis factor (TNF) treatment in patients with …